Matthieu Boucher, Ph.D.
Psychiatry, Central Nervous System, Women’s Health & Allergy

National Field Manager, Medical Affairs, Neurosciences
Otsuka Canada Pharmaceutical Inc.
2250, boul. Alfred-Nobel, bureau 301
Ville Saint-Laurent, Québec H4S 2C9

Lionel Breton, Ph.D.
CILIA Consulting, Cofounder, CEO

Ìý

CILIA Consulting
20 avenue de Paris
78000 Versailles, FR

Ìý

Ìý

Email: btwocg [at] gmail.com
Tel: +33 6 63 18 99 38
Fax: +33 6 17 05 15 38

Lorella Garofalo, Ph.D.
Head of Regulatory Affairs, Canada

Email: lorella.garofalo [at] pfizer.com
Tel: 514-426-7432
Fax: 514-426-6824
Web: | | @PfizerCA

John W. Gillard, Ph.D.

Ìý

SVP Research and Product Development
Kalgene Pharmaceuticals Inc.

Email: John.gillard [at] kalgene.com
Tel: 514 887-8632

Ìý

Joseph Mancini, Ph.D.
Head of Biology; Sr Director at adMare BioInnovations
Diabetes/Inflammation

adMare's Innovation Centre
7171 Frederick-Banting
Montreal, Quebec H4S 1Z9

Email:joseph.mancini [at] mcgill.ca"> joseph.mancini [at] mcgill.ca
Tel: 617-691-7534

Karen Meerovitch, Ph.D
Vice-President, Clinical Development
Drug/clinical development Ophthalmology

Vice-President, Clinical Development
Mimetogen Pharmaceuticals, Inc.
1000 de La Gauchetière St. West
Suite 900
Montréal, Québec H3B 5H4

Email: karen.meerovitch [at] mimetogen.com
Tel: 514-924-7484

Taylor Cohen, Ph.D
Director – Discovery Microbiome
Early Vaccines and Immune Therapies

AstraZeneca
BioPharmaceuticlas R&D | Microbial Sciences
One Medimmune Way, Gaithersburg, MD 20878

Christopher Wright, Ph.D.
Chief Development Officer & SVP-Global Development
Ironwood Pharmaceuticals Inc

Ìý

Chief Development Officer & SVP-Global Development
Ironwood Pharmaceuticals Inc
100 Summer Street
Suite 2300
Boston MA 02110

Email: ciwright1983 [at] comcast.net
Web:

sandra.aube-lenglin [at] mcgill.ca